The DOI matches its Crossref record; 39 of the 41 references it cites were found in a registry or an index.
Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis
Open accessAbstract
Background: Anxiety, depression and fatigue are commonly reported by persons with multiple sclerosis (PwMS). Objectives: We estimated the prevalence of each factor in a representative sample of PwMS, and in subgroups defined by age, sex and disease duration, at cohort entry and over time. We further examined whether and how these factors clustered together. Methods: A population-based longitudinal cohort of 198 PwMS was followed 6-monthly for 2.5 years. The Hospital Anxiety and Depression Scale (HADS) was used to measure anxiety (cut-point >7) and depression (>7) and the Fatigue Severity Scale (FSS) to measure fatigue (≥5). Results: At cohort entry, prevalence of anxiety was 44.5% (95%CI 37–51%), depression 18.5% (95%CI 12.6–23.4%), and fatigue 53.7% (95%CI 47–61%). Fatigue was more common in males than females (RR 1.29, p =0.01), with attenuation of the effect after adjustment for Expanded Disability Status Scale (adjusted RR 1.18, p =0.13). Prevalence of anxiety (but not depression or fatigue) decreased by 8.1% per year of cohort observation (RR 0.92, 95%CI 0.86–0.98, p =0.009), with the effect more pronounced in women (14.6%, RR 0.85, 95%CI 0.79–0.93, –<0.001) than men (2.6%, RR 1.03, 95%CI 0.90–1.17, p =0.77). There was no apparent seasonal variation in the prevalence of any of the three factors ( p >0.05). All three factors occurred contemporaneously at cohort entry in a higher proportion of the cohort than expected by chance ( p <0.001). Conclusions: Anxiety, depression and fatigue are common in PwMS and tend to cluster together. The findings are important for clinical management of PwMS and to the exploration of possible shared causal biological pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The lifetime prevalence of anxiety disorders ranges from 20% to 45% throughout the course of MS,1”
From EMDR treatment for anxiety in MS patients: A pilot study (2020) · cites this paper as [1]
In the citing paper
“Multiple sclerosis (MS) patients suffer from high levels of anxiety.”
From EMDR treatment for anxiety in MS patients: A pilot study (2020) · cites this paper as [1]
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
The validity of the Hospital Anxiety and Depression Scale
Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00296-3 · Cited by 9,779
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Krupp, L. B. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520460115022 · Cited by 6,172
Multiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity
Roxburgh, R. H. S. R., Seaman, S. R., Masterman, T., Hensiek, A. E., Sawcer, S. J., Vukusic, S., Achiti, I., Confavreux, C., Coustans, M., le Page, E., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000156155.19270.f8 · Cited by 963
Parsons, H. M. (1974) · Science · doi:10.1126/science.183.4128.922 · Cited by 615
Chwastiak, L., Ehde, D. M., Gibbons, L. E., Sullivan, M., Bowen, J. D., & Kraft, G. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1862 · Cited by 555
Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis
Simpson, S., Taylor, B. V., Blizzard, L., Ponsonby, A., Pittas, F., Tremlett, H. L., Dwyer, T., Gies, P. H., & van der Mei, I. A. F. (2010) · Annals of Neurology · doi:10.1002/ana.22043 · Cited by 481
Self-citationFatigue in multiple sclerosis and its relationship to depression and neurologic disability
Bakshi, R., Shaikh, Z. A., Miletich, R. S., Czarnecki, D., Dmochowski, J., Henschel, K., Janardhan, V, Dubey, N., & Kinkel, P. R. (2000) · Multiple Sclerosis Journal · doi:10.1177/135245850000600308 · Cited by 480
Cited by
Sorted by citations
The Role of Inflammation in Depression and Fatigue
Lee, C.-H., & Giuliani, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01696 · Cited by 662
The link between multiple sclerosis and depression
Feinstein, A., Magalhaes, S., Richard, J., Audet, B., & Moore, C. S. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.139 · Cited by 550
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
Marrie, R. A., Reingold, S., Cohen, J., Stuve, O., Trojano, M., Sorensen, P. S., Cutter, G., & Reider, N. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514564487 · Cited by 519
Exercise in patients with multiple sclerosis
Motl, R. W., Sandroff, B. M., Kwakkel, G., Dalgas, U., Feinstein, A., Heesen, C., Feys, P., & Thompson, A. J. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30281-8 · Cited by 459
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
Marrie, R., Cohen, J., Stüve, O., Trojano, M., Sørensen, P., Reingold, S., Cutter, G., & Reider, N. (2015) · Multiple Sclerosis · doi:10.1177/1352458514564491 · Cited by 762
Effects of Exercise Training on Fatigue in Multiple Sclerosis
Pilutti, L. A., Greenlee, T. A., Motl, R. W., Nickrent, M. S., & Petruzzello, S. J. (2013) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31829b4525 · Cited by 279
Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review
Ramirez, A. O., Keenan, A., Kalau, O., Worthington, E., Cohen, L., & Singh, S. R. (2021) · BMC Neurology · doi:10.1186/s12883-021-02396-1 · Cited by 273
Pilutti, L., Dlugonski, D., Sandroff, B. M., Klaren, R. E., & Motl, R. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513503391 · Cited by 196
Sanai, S. A., Saini, V. A., Benedict, R. H. B., Zivadinov, R., Teter, B. E., Ramanathan, M. K., & Weinstock‐Guttman, B. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516634871 · Cited by 184
for the CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis, Marrie, R. A., Fisk, J. D., Yu, B. N., Leung, S., Elliott, L., Caetano, P., Warren, S., Evans, C., Wolfson, C., et al. (2013) · BMC Neurology · doi:10.1186/1471-2377-13-16 · Cited by 163
“Graphical analysis of misclassification bias suggested that the case definitions perform reasonably well in the expected range of prevalence for mental comorbidity in MS (Additional file 8: Figure S1) [1,2,22-28].”
BackgroundDepression in Multiple Sclerosis: Epidemiology, Aetiology, Diagnosis and Treatment
Solaro, C. M., Gamberini, G., & Masuccio, F. G. (2018) · CNS Drugs · doi:10.1007/s40263-018-0489-5 · Cited by 171
Rooney, S., Wood, L., Moffat, F., & Paul, L. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.01.011 · Cited by 152
“However, the findings from the overall study population confirm the results from previous studies that demonstrate fatigue is associated with physical [11, 13, 24], psychological [20, 21], and cognitive outcomes [17, 29] and, therefore, highlight the multifactorial and debilitating impact of fatigue in MS.”
BackgroundResultInfluentialWork-related problems in multiple sclerosis: a literature review on its associates and determinants
Raggi, A., Covelli, V., Schiavolin, S., Scaratti, C., Leonardi, M., & Willems, M. (2015) · Disability and Rehabilitation · doi:10.3109/09638288.2015.1070295 · Cited by 145
Koelmel, E., Hughes, A. J., Alschuler, K. N., & Ehde, D. M. (2016) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2016.09.127 · Cited by 144
Prevalence of fatigue in Parkinson disease and its clinical correlates
Stocchi, F., Abbruzzese, G., Ceravolo, R., Cortelli, P., D’Amelio, M., Pandis, M. F. D., Fabbrini, G., Pacchetti, C., Pezzoli, G., Tessitore, A., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000587 · Cited by 131
Burden of multiple sclerosis on direct, indirect costs and quality of life: National US estimates
Campbell, J. D., Ghushchyan, V. H., McQueen, R. B., et al. (2013) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2013.09.004 · Cited by 126
Svenningsson, A., Eva, F., Celius, E. G., Fuchs, S., Schreiber, K. I., Berkö, S., Sun, J., Penner, I., & for the TYNERGY trial investigators (2013) · PLoS ONE · doi:10.1371/journal.pone.0058643 · Cited by 116
A systematic review of anxiety amongst people with Multiple Sclerosis
Butler, E., Matcham, F., & Chalder, T. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2016.10.003 · Cited by 111
Henry, A., Tourbah, A., Camus, G., Deschamps, R., Mailhan, L., Castex, C., Gout, O., & Montreuil, M. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.09.039 · Cited by 95
Hauer, L., Perneczky, J., & Sellner, J. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10107-y · Cited by 98
Harrison, A. M., Safari, R., Mercer, T. H., Picariello, F., van der Linden, M. L., White, C. M., Moss-Morris, R. E., & Norton, S. (2021) · Multiple Sclerosis Journal · doi:10.1177/1352458521996002 · Cited by 97
“Exploring if fatigue-targeted interventions (intervention exclusively designed with an aim to reduce fatigue) have larger effects than nonfatigue-targeted interventions, including some predefined within category comparisons (1) cognitive behavioural therapy (CBT) for depression, where fatigue is measured as a secondar…”
BackgroundMethodLoy, B. D., Taylor, R. L., Fling, B. W., & Horak, F. B. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.06.017 · Cited by 91
Terrill, A. L., Hartoonian, N., Beier, M. L., Salem, R., & Alschuler, K. N. (2014) · International Journal of MS Care · doi:10.7224/1537-2073.2014-008 · Cited by 84
Recommendations for observational studies of comorbidity in multiple sclerosis
Marrie, R. A., Miller, A., Sormani, M. P., Thompson, A. J., Waubant, E. L., Trojano, M., O'Connor, P. W., Fiest, K. M., Reider, N., Reingold, S. C., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002474 · Cited by 82
Charvet, L. E., Serafin, D., & Krupp, L. (2013) · Fatigue Biomedicine Health & Behavior · doi:10.1080/21641846.2013.843812 · Cited by 83
Meditation as an adjunct to the management of multiple sclerosis.
Levin, A. B., Hadgkiss, E. J., Weiland, T. J., & Jelinek, G. A. (2014) · Neurology Research International · doi:10.1155/2014/704691 · Cited by 77
Aging with multiple sclerosis: prevalence and profile of cognitive impairment
Branco, M., Ruano, L., Portaccio, E., Goretti, B., Niccolai, C., Patti, F., Chisari, C. G., Gallo, P., Grossi, P., Ghezzi, A., et al. (2019) · Neurological Sciences · doi:10.1007/s10072-019-03875-7 · Cited by 80
Kobelt, G., Langdon, D. W., & Jönsson, L. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518769837 · Cited by 76
Kolahkaj, B., & Zargar, F. (2015) · Nursing and Midwifery Studies · doi:10.17795/nmsjournal29655 · Cited by 77
“Another study reported that approximately 48% of patients with MS experience anxiety, stress and depression in the first year after the diagnosis (7).”
BackgroundBackus, D. A., Manella, C., Bender, M. A., & Sweatman, M. (2016) · International Journal of Therapeutic Massage & Bodywork Research Education & Practice · doi:10.3822/ijtmb.v9i4.327 · Cited by 77
“(49-51) Other variables not studied in this study include depression(52) and sleep disorders, both common symptoms reported by people with MS.”
BackgroundAlschuler, K. N., & Beier, M. L. (2015) · International Journal of MS Care · doi:10.7224/1537-2073.2014-044 · Cited by 76
How Multiple Sclerosis Symptoms Vary by Age, Sex, and Race/Ethnicity
Kister, I., Bacon, T. E., & Cutter, G. (2021) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000001105 · Cited by 76
Symptomatic treatment and management of multiple sclerosis
Toosy, A., Ciccarelli, O., & Thompson, A. J. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52001-2.00023-6 · Cited by 79
Anxiety, emotional processing and depression in people with multiple sclerosis
Gay, M., Bungener, C., Thomas, S., Vrignaud, P., Thomas, P., Baker, R. D., Montel, S., Heinzlef, O., Papeix, C., Assouad, R., et al. (2017) · BMC Neurology · doi:10.1186/s12883-017-0803-8 · Cited by 75
Zeraati, M., Enayati, M., Kafami, L., Shahidi, S. H., & Salari, A. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107685 · Cited by 65
Increasing Physical Activity and Participation in People With Multiple Sclerosis: A Review
Backus, D. A. (2016) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2015.09.027 · Cited by 74
Fear of Falling in People With Multiple Sclerosis: Which Clinical Characteristics Are Important?
Khalil, H. W., Al‐Sharman, A., El‐Salem, K., Abdo, N. M., Alghwiri, A. A., Aburub, A., Shalabi, S., & Al-Mustafa, F. (2017) · Physical Therapy · doi:10.1093/ptj/pzx044 · Cited by 68
Efficacy and Side Effects of Natalizumab Therapy in Patients with Multiple Sclerosis
Hoepner, R., Faissner, S., Salmen, A., Gold, R., & Chan, A. (2014) · Journal of Central Nervous System Disease · doi:10.4137/jcnsd.s14049 · Cited by 63
Vitkova, M., Gdovinova, Z., Rosenberger, J., Szilasiova, J., Nagyová, I., Mikula, P., Krokavcova, M., Groothoff, J. W., & van Dijk, J. P. (2014) · Disability and health journal · doi:10.1016/j.dhjo.2014.05.004 · Cited by 63
“On the other hand, patients with longer disease duration have already adjusted to the presence of disease,(29) and the role of depression is more significant regarding the progressive disability and impairment in ambulatory status.(30) Next, we found that pain was the strongest variable associated with poor sleep qual…”
BackgroundLongitudinal associations between mindfulness and well-being in people with multiple sclerosis
Pagnini, F., Cavalera, C., Rovaris, M., Mendozzi, L., Molinari, E., Phillips, D., & Langer, E. J. (2018) · International Journal of Clinical and Health Psychology · doi:10.1016/j.ijchp.2018.11.003 · Cited by 70
Depression in multiple sclerosis: Is one approach for its management enough?
Jones, C. D., Motl, R. W., & Sandroff, B. M. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102904 · Cited by 64
Nigro, S. L., Passamonti, L., Riccelli, R., Toschi, N., Rocca, F., Valentino, P., Nisticò, R., Fera, F. S., & Quattrone, A. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514558474 · Cited by 61
Fatigue and Comorbidities in Multiple Sclerosis
Fiest, K. M., Fisk, J. D., Patten, S. B., Tremlett, H. L., Wolfson, C. M., Warren, S., McKay, K. A., Berrigan, L. I., Marrie, R. A., & for the CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS) (2016) · International Journal of MS Care · doi:10.7224/1537-2073.2015-070 · Cited by 63
Prevalence of neuropathic pain in early multiple sclerosis
Heitmann, H., Biberacher, V., Tiemann, L., Buck, D., Loleit, V., Selter, R., Knier, B., Tölle, T. R., Mühlau, M., Berthele, A., et al. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515613643 · Cited by 59
Neural mechanisms underlying state mental fatigue in multiple sclerosis: a pilot study
Chen, M. H., Wylie, G. R., Sandroff, B. M., Dacosta‐Aguayo, R., DeLuca, J., & Genova, H. M. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09853-w · Cited by 56
Zolbanin, J. M., Doosti, M.-H., Kosari‐Nasab, M., & Salari, A. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.016 · Cited by 57
“In line with these findings, clinical studies have shown that anxiety and depression are often considered the most common neuropsychological disorders influencing MS patients (Wallin et al., 2006, Wood et al., 2012).”
InfluentialTaylor, E. C., & Taylor‐Piliae, R. E. (2017) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2017.03.001 · Cited by 59
Anxiety, depression and fatigue at 5‐year review following CNS demyelination
Simpson, S., Tan, H., Otáhal, P., Taylor, B. V., Ponsonby, A., Lucas, R. M., Blizzard, L., Valery, P. C., Lechner‐Scott, J., Shaw, C., et al. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12554 · Cited by 61
“65 times that expected under statistical independence (26).”
BackgroundResultInfluentialSelf-citationBattalio, S. L., Huffman, S. E., & Jensen, M. P. (2020) · Health Psychology · doi:10.1037/hea0000848 · Cited by 70
“For example, research has found significant associations between anxious and depressive symptoms and pain, fatigue, physical functioning, self-reported and objective cognitive function, and social functioning (Asmundson & Katz, 2009; Battalio et al., 2018; Korostil & Feinstein, 2007; Lester, Stepleman, & Hughes, 2007;…”
BackgroundAnxiety disorder among rheumatoid arthritis patients: Insights from real-life data
Watad, ., Bragazzi, N. L., Adawi, M., Aljadeff, G., Amital, H., Comaneshter, D. S., Cohen, A. D., & Amital, D. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.02.007 · Cited by 55
Valentine, T. R., Alschuler, K. N., Ehde, D. M., & Kratz, A. L. (2022) · Multiple Sclerosis Journal · doi:10.1177/13524585211023352 · Cited by 55
Mental Health Comorbidity in MS: Depression, Anxiety, and Bipolar Disorder
Turner, A. P., Alschuler, K. N., Hughes, A. J., Beier, M. L., Haselkorn, J. K., Sloan, A. P., & Ehde, D. M. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-016-0706-x · Cited by 55
Ohle, L.-M., Ellenberger, D., Flachenecker, P., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-92722-x · Cited by 53
Jiang, J., Chu, C., Wu, C., Wang, C., Zhang, C., Li, T., Zhai, Q., Yu, L., Tian, F., & Chen, W. (2021) · Food & Function · doi:10.1039/d0fo03203d · Cited by 52
Cognitive Impairment in Multiple Sclerosis: A Review of Neuropsychological Assessments
Korakas, N., & Tsolaki, M. (2016) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000097 · Cited by 52
Sexual dysfunction levels in iranian women suffering from multiple sclerosis
Nayeri, N. D., Khakbazan, Z., Ghafoori, F., & Nabavi, S. M. (2017) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.01.005 · Cited by 51
Kiropoulos, L. A., Kilpatrick, T., Holmes, A., & Threader, J. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1152-7 · Cited by 50
“Similarly, anxiety affects between 16 and 45% of the MS population [7, 8] and has been associated with younger age of onset, disease severity, fatigue [9] and severity of depressive symptoms [10].”
BackgroundNakazawa, K., Noda, T., Ichikura, K., Okamoto, T., Takahashi, Y., Yamamura, T., & Nakagome, K. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.08.023 · Cited by 50
Predictors of anxiety in multiple sclerosis.
Hartoonian, N., Terrill, A. L., Beier, M. L., Turner, A. P., Day, M. A., & Alschuler, K. N. (2014) · Rehabilitation Psychology · doi:10.1037/rep0000019 · Cited by 47
“…greater MS-related disability (Jones et al., 2012), higher levels of fatigue (Beiske et al., 2008), MS exacerbations (rapid onset or an increase in symptoms; Burns, Nawacki, Siddique, Pelletier, & Mohr, 2013; Feinstein et al., 1999), and depression (Garfield & Lincoln, 2012; Wood et al., 2013).”
InfluentialFatigue, Depression, and Anxiety Among Ambulating Multiple Sclerosis Patients
AlSaeed, S., Aljouee, T., Alkhawajah, N. M., Alarieh, R., AlGarni, H., Aljarallah, S., Ayyash, M., & Abu-Shaheen, A. K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.844461 · Cited by 52
“Depression and anxiety have an unpredictable disease nature and are considered to be the most disabling symptoms that affect the QoL and general health in MS patients (11, 12).”
BackgroundResultInfluentialChen, M. H., DeLuca, J., Genova, H. M., Yao, B., & Wylie, G. R. (2020) · Diagnostics · doi:10.3390/diagnostics10110930 · Cited by 47
“Fatigue is one of the most prevalent symptoms of multiple sclerosis (MS) [1,2], an immunemediated, neurodegenerative disorder characterized with demyelination, axonal injury, and brain atrophy.”
BackgroundWilliams, A., Vietri, J., Isherwood, G., & Flor, A. (2014) · Multiple Sclerosis International · doi:10.1155/2014/203183 · Cited by 46
“Indeed, research has documented that fatigue, depression, and anxiety are observed together at higher-than-chance levels among individuals with multiple sclerosis (MS) and vary together [2, 3].”
BackgroundQuality of life and coping strategies in Lebanese multiple sclerosis patients: a pilot study
Farran, N., Ammar, D., & Darwish, H. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.12.003 · Cited by 42
Metacognition and self-awareness in Multiple Sclerosis
Mazancieux, A., Souchay, C., Casez, O., & Moulin, C. J. A. (2018) · Cortex · doi:10.1016/j.cortex.2018.11.012 · Cited by 45
Kos, D., Duportail, M., Meirte, J., Meeus, M., D'hooghe, M. B., Nagels, G., Willekens, B. M. P., Meurrens, T., Ilsbroukx, S., & Nijs, J. (2016) · International Journal of Rehabilitation Research · doi:10.1097/mrr.0000000000000178 · Cited by 44
“Introduction Fatigue is one of the most common and bothersome symptoms in multiple sclerosis (MS) patients and is reported in 50–92% of the MS population (Wood et al., 2013; Patti and Vila, 2014).”
BackgroundAnxiety in multiple sclerosis is related to depressive symptoms and cognitive complaints
Wallis, O. C., Bol, Y., Köhler, S., & Heugten, C. M. V. (2019) · Acta Neurologica Scandinavica · doi:10.1111/ane.13191 · Cited by 43
McKay, K. A., Tremlett, H. L., Fisk, J. D., Patten, S. B., Fiest, K. M., Berrigan, L. I., Marrie, R. A., & for the CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS) (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515599073 · Cited by 42
Third wave cognitive behavioural therapies for people with multiple sclerosis: a scoping review
Zarotti, N., Eccles, F., Broyd, A., Longinotti, C., Mobley, A., & Simpson, J. (2023) · Disability and Rehabilitation · doi:10.1080/09638288.2022.2069292 · Cited by 40
Psychometric properties of the Hamilton Depression Rating Scale in multiple sclerosis
Raimo, S., Trojano, L., Spitaleri, D. L. A., Petretta, V., Grossi, D., & Santangelo, G. (2015) · Quality of Life Research · doi:10.1007/s11136-015-0940-8 · Cited by 40
“[2–5]), for reasons likely related to divergent criteria for patient selection, and to the different measures used to”
BackgroundAlsaadi, T. M., Hammasi, K. E., Shahrour, T. M., Shakra, M., Turkawi, L., Mudhafar, A., Diab, L., & Raoof, M. (2015) · Multiple Sclerosis International · doi:10.1155/2015/487159 · Cited by 41
“Indeed, a recent study has shown that patients with EDSS scores less than 3, similar to our cohorts, were at least twice less likely to suffer from depression and/or anxiety [26].”
BackgroundRecovery From COVID-19 in Multiple Sclerosis
Garjani, A., Middleton, R., Nicholas, R. S., & Evangelou, N. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001118 · Cited by 40
Ensari, I., Sandroff, B. M., & Motl, R. W. (2015) · International Journal of MS Care · doi:10.7224/1537-2073.2014-104 · Cited by 38
Barakou, I., Hackett, K. L., Finch, T. L., & Hettinga, F. J. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2270688 · Cited by 49
“More specifically, in multiple sclerosis, depression and anxiety are considered as highly debilitating symptoms that significantly impact individuals’ quality of life while pain and fatigue have also been associated with anxiety [166,167].”
BackgroundPoint prevalence and correlates of depression in a national community sample with multiple sclerosis
Viner, R., Fiest, K. M., Bulloch, A. G. M., Williams, J. V. A., Lavorato, D. H., Berzins, S. A., Jetté, N., Metz, L. M., & Patten, S. B. (2014) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2013.12.011 · Cited by 36
“5% was reported, approximately twice the reported prevalence in an otherwise comparable non-MS population [3].”
BackgroundMethodBahrani, S., Zargar, F., Yousefipour, G., & Akbari, H. (2017) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.44566 · Cited by 36
“Depression is one of the most common psychiatric symptoms diagnosed in patients with MS (10), the prevalence of which was reported to be 23.7% in a recent review study (11).”
BackgroundInfluentialDepression and anxiety in multiple sclerosis. Review of a fatal combination
Jellinger, K. A. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02792-0 · Cited by 48
“…more frequent (AlSaeed et al. 2022; Jones et al. 2012; Koltuniuk and Rosinczuk 2021; Mustac et al. 2021 ; Shafiee et al. 2023; Simpson et al. 2016; Wood et al. 2013) or less frequent than depression (Alharbi et al. 2022; Alswat et al. 2023; Bamer et al. 2008; Boeschoten et al. 2017; Marrie et al.…”
InfluentialFatigue in multiple sclerosis: A UK MS-register based study
Moore, H., Nair, K. P. S., Baster, K., Middleton, R., Paling, D., & Sharrack, B. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103954 · Cited by 37
Is Personality Profile a Relevant Determinant of Fatigue in Multiple Sclerosis?
Schreiber, H., Lang, M., Kiltz, K., & Lang, C. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00002 · Cited by 37
“A recent study has emphasized that the prevalence of the three factors is high in MS, with depression rarely occurring alone or without concurrent anxiety and/or fatigue (27).”
Backgroundvan Gorp, D. A. M., van der Hiele, K., Heerings, M. A. P., Jongen, P. J., van der Klink, J. J. L., Reneman, M. F., Arnoldus, E. P. J., Beenakker, E. A. C., van Eijk, J. J. J., Frequin, S. T. F. M., et al. (2019) · Neurological Sciences · doi:10.1007/s10072-019-03999-w · Cited by 36
Fatigue and Affective Manifestations in Multiple Sclerosis—A Cluster Approach
Ayache, S., & Chalah, M. A. (2019) · Brain Science · doi:10.3390/brainsci10010010 · Cited by 28
Zanten, J. V., Douglas, M. R., & Ntoumanis, N. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102602 · Cited by 35
Intensity of treadmill walking exercise on acute mood symptoms in persons with multiple sclerosis
Ensari, I., Sandroff, B. M., & Motl, R. W. (2016) · Anxiety Stress & Coping · doi:10.1080/10615806.2016.1146710 · Cited by 35
“The average disease duration was 8.1 ± 6.8 years and the median EDSS was 3.0, which indicates that on average, the sample was fully ambulatory with mild-to-moderate disability (Kurtzke, 1983).”
BackgroundResultInfluentialThe relationship between cognitive fusion, stigma, and well-being in people with multiple sclerosis
Valvano, A., Floyd, R. M., Penwell-Waines, L., Stepleman, L., Lewis, K., & House, A. (2016) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2016.07.003 · Cited by 32
Zhang, X., Song, Y., Wei, Z., Chen, X., Zhuang, X., & Li, Y. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1120541 · Cited by 38
Negaresh, R., Motl, R. W., Mokhtarzade, M., Ranjbar, R., Majdinasab, N., Khodadoost, M., Zimmer, P., Baker, J. S., & Patel, D. I. (2018) · EXPLORE · doi:10.1016/j.explore.2018.07.007 · Cited by 33
“, interferon beta).(3,6) Fatigue and depression are commonly accompanied by disability progression,(2,7) and fatigue and depression symptoms may reduce physical activity and quality of life in persons with MS.”
BackgroundHistory of fatigue in multiple sclerosis is associated with grey matter atrophy
Palotai, M., Nazeri, A., Cavallari, M., Healy, B. C., Glanz, B. I., Gold, S. M., Weiner, H. L., Chitnis, T., & Guttmann, C. R. G. (2019) · Scientific Reports · doi:10.1038/s41598-019-51110-2 · Cited by 33
Chalah, M. A., Grigorescu, C., Padberg, F., Kümpfel, T., Palm, U., & Ayache, S. S. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02166-2 · Cited by 36
Sparasci, D., Gobbi, C., Castelnovo, A., Riccitelli, G. C., Disanto, G., Zecca, C., & Manconi, M. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11143-6 · Cited by 38
Askey-Jones, S., David, A. S., Silber, E., Shaw, P., & Chalder, T. (2013) · Behaviour Research and Therapy · doi:10.1016/j.brat.2013.04.001 · Cited by 32
Gavrilov, Y. V., Shkilnyuk, G. G., Valko, P. O., Stolyarov, I. D., Ивашкова, Е. В., Ilves, A. G., Nikiforova, I. G., Shchelkova, O. Y., Wasserman, L. I., Vais, E. E., et al. (2018) · Acta Neurologica Scandinavica · doi:10.1111/ane.12993 · Cited by 32
Vesić, K., Tončev, G., Drakulić, S. M., & Borovčanin, M. (2018) · Acta Neurologica Belgica · doi:10.1007/s13760-018-1015-8 · Cited by 38
Mayo, C. D., Miksche, K., Attwell-Pope, K., & Gawryluk, J. R. (2019) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2019.1614535 · Cited by 32
“…& Zivadinov, 2011; Chiaravalloti & DeLuca, 2008; Planche et al., 2016); up to 50% of individuals diagnosed with MS have experienced depression (Feinstein, Magalhaes, Richard, Audet, & Moore, 2014) and 50% to 80% of individuals with MS experience fatigue (Wood et al., 2012; Zajicek et al., 2010).”
BackgroundMS Energize: Field trial of an app for self-management of fatigue for people with multiple sclerosis
Babbage, D. R., van Kessel, K., Drown, J., Thomas, S., Sezier, A., Thomas, P., & Kersten, P. (2019) · Internet Interventions · doi:10.1016/j.invent.2019.100291 · Cited by 32
Simpson, R., Simpson, S., Wasilewski, M., Mercer, S., & Lawrence, M. (2022) · Disability and Rehabilitation · doi:10.1080/09638288.2021.1964622 · Cited by 30
Battalio, S. L., Glette, M., Alschuler, K. N., & Jensen, M. P. (2018) · Rehabilitation Psychology · doi:10.1037/rep0000231 · Cited by 30
Butchard-MacDonald, E., Paul, L., & Evans, J. J. (2017) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617717000947 · Cited by 28
“Estimated prevalence rates for depression range from 10% to 41.8%; anxiety 23.5% to 41%, which are considerably higher than in the general population (Wood et al., 2012).”
BackgroundInfluentialSkorve, E., Lundervold, A. J., Torkildsen, Ø., & Myhr, K. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102577 · Cited by 30
Simpson, R., Posa, S., Langer, L. K., Bruno, T. R., Simpson, S., Lawrence, M., Booth, J., Mercer, S. W., Feinstein, A., & Bayley, M. T. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11451-x · Cited by 29
“Common symptoms include stress [3], anxiety [4], depression [5], fatigue [6], spasticity [7], pain [8], temperature sensitivity [9], cognitive difficulties [10], sleep impairment [11], bowel [12], bladder [13] and sexual dysfunction [14].”
BackgroundMood and coping in clinically isolated syndrome and multiple sclerosis
Bianchi, V., Giglio, L. D., Prosperini, L., Mancinelli, C. R., Angelis, F. D., Barletta, V. T., & Pozzilli, C. (2013) · Acta Neurologica Scandinavica · doi:10.1111/ane.12194 · Cited by 29
“Strong associations have been observed between depression and anxiety (12).”
BackgroundConnaughton, J., & Gibson, W. (2016) · Physiotherapy Canada. Physiothérapie Canada · doi:10.3138/ptc.2015-66 · Cited by 26
Metadata
- Authors
- Wood, B., van der Mei, I., Ponsonby, A.-L., Pittas, F., Quinn, S., Dwyer, T., Lucas, R., & Taylor, B.
- Affiliations
- University of Tasmania (AU)
- Menzies Research Institute Tasmania, University of Tasmania, Tasmania, Australia
- The University of Melbourne (AU)
- Flinders University (AU)
- National Centre for Epidemiology and Public Health, The Australian National University, Canberra, Australia
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2012-06-22
- Volume
- 19
- Issue
- 2
- Pages
- 217-224
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- OpenAlex
- W1973836236
- Cited by
- 294
- References
- 41
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 17 · 2023: 15 · 2022: 24 · 2021: 36 · 2020: 21 · 2019: 19 · 2018: 25 · 2017: 22 · 2016: 24 · 2015: 25 · 2014: 28 · 2013: 19 · 2012: 1
- FWCI
- 16.84
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Locations
- Multiple Sclerosis Journal (publishedVersion)
- PubMed (publishedVersion)
- eCite Digital Repository (University of Tasmania) (submittedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- ANU Open Research (Australian National University) (submittedVersion)
- Swinburne figshare (Swinburne University of Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- multiple sclerosis, anxiety, depression, fatigue, comorbidities, prevalence, longitudinal cohort, sex differences, disease duration, Expanded Disability Status Scale, seasonal variation, Hospital Anxiety and Depression Scale, Fatigue Severity Scale
- MeSH terms
- Adult, Age Factors, Antidepressive Agents, Anxiety, Depression, Disability Evaluation, Educational Status, Fatigue, Female, Humans, Immunologic Factors, Longitudinal Studies, Male, Middle Aged, Multiple Sclerosis, Seasons, Sex Characteristics, Tasmania, Cohort Studies, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review